US Biosimilar Approvals Soar in 2017

Published date19 December 2017
Law FirmPatterson Belknap Webb & Tyler LLP
AuthorIrena Royzman,Jacob Siegel
Subject MatterFDA,Prescription Drugs,Biosimilars,Pfizer,Biologics,Amgen,Mylan Pharmaceuticals,Allergan Inc,Sandoz,Boehringer,Commercial Marketing,Hospira,Pharmaceutical Industry

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT